{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:33:04Z","timestamp":1788489184335,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The role of viral infections in multiple sclerosis (MS) pathogenesis is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Certain neurotropic viruses previously linked with MS among white population were studied including Epstein\u2013Barr virus, human herpesvirus-6 (HHV-6) and MS-associated retrovirus (MSRV).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>Sixty-two MS patients (37 had a recent clinical relapse) and 65 controls with other neurological disorders were included. Blood and cerebrospinal fluid (CSF) samples were obtained and processed with the primary objective of determining whether there was intrathecal multiplication of viruses under study (EBV, HHV6 A and B and human endogenous retrovirus) or a breach in blood\u2013brain barrier associated with viral presence in both peripheral blood and CSF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Evidence of breach in blood\u2013brain barrier was seen in 86.5% of patients as evidenced by abnormal CSF\/serum albumin index and or MRI. EBV nuclear antigen (EBNA1 IgG) was seen in 89% of MS patients and 58% controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = &lt;0.001). However, HHV6 IgG was similar in both groups (85% versus 81%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.45). In affinity immunoblotting reaction intrathecal IgG synthesis against EBNA1 antigen was demonstrable in 26% (16\/62) of patients and none against HHV6. A subset of patients showed significant elevation in mean copy number of plasma EBV DNA during relapse and there was a trend for the same among patients harboring HHV-6B. No evidence of isolated intrathecal viral presence or multiplication was seen.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The results of our study suggest that viruses studied namely EBV and HHV6 have a role in triggering relapses through a peripheral mechanism, rather than a direct role through intrathecal multiplication.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0028-3886.319209","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T02:21:28Z","timestamp":1640658088000},"page":"681-685","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Role of Viral Infections in Multiple Sclerosis Pathogenesis among Indian Population"],"prefix":"10.4103","volume":"69","author":[{"given":"Lekha","family":"Pandit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaithra","family":"Malli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitha","family":"D'Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshatha","family":"Sudhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-30-20240907","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/08828240050144590","article-title":"Viruses and multiple sclerosis","volume":"13","author":"Cermelli","year":"2000","journal-title":"Viral Immunol"},{"key":"R2-30-20240907","doi-asserted-by":"crossref","first-page":"e0124064","DOI":"10.1371\/journal.pone.0124064","article-title":"Environmental factors related to multiple sclerosis in Indian population","volume":"10","author":"Malli","year":"2015","journal-title":"PLoS One"},{"key":"R3-30-20240907","first-page":"47","article-title":"A case control study of environmental risk factors in Indians with multiple sclerosis","volume":"10","author":"Khadilkar","year":"2005","journal-title":"Neurol Asia"},{"key":"R4-30-20240907","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2012.12.004","article-title":"Association of Epstein-Barr virus infection with multiple sclerosis in India","volume":"325","author":"Pandit","year":"2013","journal-title":"J Neurol Sci"},{"key":"R5-30-20240907","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1073\/pnas.92.16.7440","article-title":"Plaque-associated expression of human herpesvirus 6 in multiple sclerosis","volume":"92","author":"Challoner","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R6-30-20240907","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jneuroim.2011.06.012","article-title":"Intrathecal human herpes virus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid","volume":"237","author":"Virtanen","year":"2011","journal-title":"J Neuroimmunol"},{"key":"R7-30-20240907","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-510X(99)00298-1","article-title":"Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis","volume":"173","author":"Rand","year":"2000","journal-title":"J Neurol Sci"},{"key":"R8-30-20240907","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.55.2.178","article-title":"Association between clinical disease activity and Epstein-Barr virus reactivation in MS","volume":"55","author":"Wandinger","year":"2000","journal-title":"Neurology"},{"key":"R9-30-20240907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(98)00067-9","article-title":"Herpesviruses\u2014a rationale for antiviral treatment in multiple sclerosis","volume":"41","author":"Bergstr\u00f6m","year":"1999","journal-title":"Antiviral Res"},{"key":"R10-30-20240907","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.410260218","article-title":"Isolation of herpes simplex type 1 during first attack of multiple sclerosis","volume":"26","author":"Bergstr\u00f6m","year":"1989","journal-title":"Ann Neurol"},{"key":"R11-30-20240907","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbadis.2010.07.016","article-title":"Human endogenous retroviruses and multiple sclerosis: Innocent bystanders or disease determinants?","volume":"1812","author":"Antony","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"R12-30-20240907","doi-asserted-by":"crossref","first-page":"e53623","DOI":"10.1371\/journal.pone.0053623","article-title":"The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity","volume":"8","author":"Montojo","year":"2013","journal-title":"PLoS One"},{"key":"R13-30-20240907","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2009.04.034","article-title":"Endogenous retroviral genes, herpes viruses and gender in multiple sclerosis","volume":"286","author":"Perron","year":"2009","journal-title":"J Neurol Sci"},{"key":"R14-30-20240907","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1073\/pnas.94.14.7583","article-title":"Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis: The Collaborative Research Group on Multiple Sclerosis","volume":"94","author":"Perron","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R15-30-20240907","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/jmv.21764","article-title":"Detection of EBV viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis","volume":"82","author":"Mancuso","year":"2010","journal-title":"J Med Virol"},{"key":"R16-30-20240907","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/1352458513501233","article-title":"Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases","volume":"20","author":"Mechelli","year":"2014","journal-title":"Mult Scler"},{"key":"R17-30-20240907","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4103\/0972-2327.120474","article-title":"Optimizing the management of neuromyelitisoptica and spectrum disorders in resource poor settings: Experience from the Mangalore demyelinating disease registry","volume":"16","author":"Pandit","year":"2013","journal-title":"Ann Indian Acad Neurol"},{"key":"R18-30-20240907","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"R19-30-20240907","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0022-510X(94)90161-9","article-title":"Formulas for the quantitation of intrathecal IgG production: Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis","volume":"12","author":"Blennow","year":"1994","journal-title":"J Neurol Sci"},{"key":"R20-30-20240907","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/JCM.38.2.712-715.2000","article-title":"Development of a real-time quantitative assay for detection of Epstein-Barr virus","volume":"38","author":"Niesters","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R21-30-20240907","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archneur.59.6.929","article-title":"Active human herpesvirus 6 infection in patients with multiple sclerosis","volume":"59","author":"Lafuente","year":"2002","journal-title":"Arch Neurol"},{"key":"R22-30-20240907","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1212\/WNL.58.3.471","article-title":"Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients","volume":"58","author":"Dolei","year":"2002","journal-title":"Neurology"},{"key":"R23-30-20240907","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0140-6736(98)24001-3","article-title":"Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis","volume":"351","author":"Garson","year":"1998","journal-title":"Lancet"},{"key":"R24-30-20240907","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein-barr virus infection and multiple sclerosis: A review","volume":"5","author":"Ascherio","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"R25-30-20240907","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1212\/WNL.0b013e3181aa29fe","article-title":"Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI","volume":"73","author":"Farrell","year":"2009","journal-title":"Neurology"},{"key":"R26-30-20240907","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12974-014-0188-1","article-title":"Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies","volume":"11","author":"Castellazzi","year":"2014","journal-title":"J Neuroinflammation"},{"key":"R27-30-20240907","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1212\/WNL.0000000000008157","article-title":"Practice guideline uptake summary. Vaccine preventable infections and immunizations in multiple sclerosis. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"93","author":"Farez","year":"2019","journal-title":"Neurology"},{"key":"R28-30-20240907","doi-asserted-by":"crossref","first-page":"e105434","DOI":"10.1371\/journal.pone.0105434","article-title":"A complex role of herpes viruses in the disease process of multiple sclerosis","volume":"9","author":"Wuest","year":"2014","journal-title":"PLoS One"},{"key":"R29-30-20240907","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0000000000004412","article-title":"Epstein-Barr virus, cytomegalovirus and multiple sclerosis susceptibility: A multiethnic study","volume":"89","author":"Langer-Gould","year":"2017","journal-title":"Neurology"},{"key":"R30-30-20240907","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s13365-017-0569-1","article-title":"Prevalence of a history of prior varicella\/herpes zoster infection in multiple sclerosis","volume":"23","author":"Manouchehrinia","year":"2017","journal-title":"J Neurovirol"},{"key":"R31-30-20240907","first-page":"198","article-title":"Multiple sclerosis and measles virus","volume":"52","author":"Ohara","year":"1999","journal-title":"Jpn J Infect Dis"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.319209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:50:30Z","timestamp":1787755830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.319209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/0028-3886.319209","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}